Drug recall · February 27, 2019
Oxytocin 30 Units added to NS 500 mL recall
Why: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.
- Lots / codes
Lots: 11/27/18 3177 70650P, BUD: 02/10/2019; 11/27/18 6618 70650P, BUD: 02/10/2019; 11/28/18 7716 70650P, BUD: 02/12/19; 12/31/18 5698 70650P, BUD: 03/16/19
- Quantity
- 1460 bottles
- Company
- Advanced Pharma Inc., Houston, TX
- Distribution
- Nationwide in the USA.
- Initiated
- February 6, 2019 · Voluntary: Firm initiated
- Classified
- February 15, 2019
- Reported
- February 27, 2019
- Ended
- October 30, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxytocin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.